Will Using Semaglutide Increase Your Risk of Thyroid Cancer?
New research shows GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, ...
News-Medical.Net6h
Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes
Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...
Trina Krug on MSN35m
What If You Want a GLP-1 Alternative That’s More Natural?
There’s no denying that GLP-1 medications like Ozempic and Wegovy are having a moment. You’ve probably seen the headlines, ...
The American Journal of Managed Care5h
Semaglutide Demonstrates Enhanced Walking Capacity in ACC.25 STRIDE Data
STRIDE investigator Marc Bonaca, MD, MPH, University of Colorado School of Medicine, highlights how the data could provide insight into peripheral artery disease and type 2 diabetes treatment options.